Page last updated: 2024-08-25

chitosan and Carditis

chitosan has been researched along with Carditis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Ji, H; Jiang, D; Liu, L; Yin, L; Zhang, L; Zhao, Q1
Dong, C; Li, X; Wang, M; Xiong, S; Xu, W; Yue, Y1
Chai, D; Dong, C; Xiong, S; Xu, W; Yue, Y2
Dong, C; Fan, X; Xiong, S; Xu, W; Ye, T; Yue, Y1
Fan, X; Xiong, S; Yue, Y1
Hu, L; Jiang, Z; Xiong, S; Xu, W; Yue, Y1
Xiong, S; Xu, W; Yue, Y1

Other Studies

8 other study(ies) available for chitosan and Carditis

ArticleYear
Chitoheptaose Promotes Heart Rehabilitation in a Rat Myocarditis Model by Improving Antioxidant, Anti-Inflammatory, and Antiapoptotic Properties.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Chitosan; Disease Models, Animal; Heart; Humans; Male; Myocarditis; Rats

2020
Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.
    Clinical and vaccine immunology : CVI, 2013, Volume: 20, Issue:11

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Coxsackievirus Infections; Enterovirus B, Human; Feces; HMGB1 Protein; Immunoglobulin A, Secretory; Male; Mice; Mice, Inbred BALB C; Myocarditis; Survival Analysis; T-Lymphocytes; Vaccination; Vaccines, DNA; Viral Vaccines

2013
Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.
    Human vaccines & immunotherapeutics, 2014, Volume: 10, Issue:5

    Topics: Animals; Chitosan; Coxsackievirus Infections; DNA-Binding Proteins; Enterovirus B, Human; HeLa Cells; Humans; Immunization; Immunoglobulin A, Secretory; Male; Mice; Mice, Inbred BALB C; Myocarditis; Nasal Mucosa; Treatment Outcome; Vaccines, DNA

2014
M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.
    Vaccine, 2014, Jul-31, Volume: 32, Issue:35

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antibodies, Viral; Chitosan; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Immunity, Mucosal; Immunoglobulin A, Secretory; Immunoglobulin G; Male; Mice, Inbred BALB C; Myocarditis; T-Lymphocytes; Vaccines, DNA; Viral Load; Viral Vaccines

2014
AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis.
    Antiviral research, 2015, Volume: 119

    Topics: Administration, Intranasal; Animals; CD8-Positive T-Lymphocytes; Chitosan; Chronic Disease; Coxsackievirus Infections; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Intestinal Mucosa; Mice, Inbred BALB C; Myocarditis; Myocardium; Vaccination; Vaccines, DNA

2015
Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
    Antiviral research, 2017, Volume: 140

    Topics: Adhesins, Escherichia coli; Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Antigen-Presenting Cells; Chitosan; Coxsackievirus Infections; Enterovirus B, Human; Fimbriae Proteins; Immunity, Mucosal; Immunoglobulin A, Secretory; Mice, Inbred BALB C; Myocarditis; Vaccines, DNA; Viral Vaccines

2017
Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Virology, 2009, Apr-10, Volume: 386, Issue:2

    Topics: Administration, Intranasal; Animals; Antibodies, Viral; CD8-Positive T-Lymphocytes; Chitosan; Coxsackievirus Infections; Enterovirus B, Human; Immunity, Innate; Immunity, Mucosal; Immunization; Lymphokines; Male; Mice; Mice, Inbred BALB C; Myocarditis; Neutralization Tests; Sialoglycoproteins; Th1 Cells; Vaccines, DNA; Viral Load; Viral Vaccines

2009
Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant.
    DNA and cell biology, 2012, Volume: 31, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Antigens, Viral; Blotting, Western; Chitosan; Coxsackievirus Infections; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Immunity, Mucosal; Kaplan-Meier Estimate; Lymphokines; Male; Mice; Mice, Inbred BALB C; Myocarditis; Plasmids; Sialoglycoproteins; T-Lymphocytes; Vaccines, DNA

2012